Stock Market News
Tissue Regenix begins sales of 'DermaPure' from CellRight Texas facility
(WebFG News) - Regenerative medical devices company Tissue Regenix Group announced on Tuesday that, following the successful completion of the manufacturing technical transfer, it has begun sales of 'DermaPure' products processed at the CellRight Technologies facility in San Antonio, Texas.
The AIM-traded firm said the completion of the transfer of DermaPure, ahead of schedule, would bring a number of benefits to the group, including the expansion of manufacturing capabilities to meet increasing demands from global sales and distribution partners.
It would also improve supply chain production efficiency, and product life cycle management, with process enhancements increasing DermaPure's shelf life from two to three years, and in-house manufacturing facilitating the augmentation of the product portfolio, Tissue Regenix's board explained.
Commercialised under the recently rebranded TRX BioSurgery division, it said DermaPure was being utilised in an increased number of clinical applications, including acute and chronic wound care, orthopaedic trauma, dental, and following the exclusive distribution agreement with ARMS medical, urogynaecology and urology.
"We are extremely encouraged by the continued progress integrating CellRight into the Tissue Regenix Group," said CEO Steve Couldwell.
"Completing the transfer of DermaPure manufacturing to our CellRight facility was achieved, ahead of schedule, and incorporated significant process improvements which is a testament to the CellRight team."
Couldwell said the move was an "important strategic milestone" in the group's long-term commercial strategy, and he was "pleased" that the operational synergies were developing as expected.
"As a result we now have greater flexibility to explore new product opportunities to meet patient demand, expanding the markets we operate in with a reduced manufacturing risk profile."
The AIM-traded firm said the completion of the transfer of DermaPure, ahead of schedule, would bring a number of benefits to the group, including the expansion of manufacturing capabilities to meet increasing demands from global sales and distribution partners.
It would also improve supply chain production efficiency, and product life cycle management, with process enhancements increasing DermaPure's shelf life from two to three years, and in-house manufacturing facilitating the augmentation of the product portfolio, Tissue Regenix's board explained.
Commercialised under the recently rebranded TRX BioSurgery division, it said DermaPure was being utilised in an increased number of clinical applications, including acute and chronic wound care, orthopaedic trauma, dental, and following the exclusive distribution agreement with ARMS medical, urogynaecology and urology.
"We are extremely encouraged by the continued progress integrating CellRight into the Tissue Regenix Group," said CEO Steve Couldwell.
"Completing the transfer of DermaPure manufacturing to our CellRight facility was achieved, ahead of schedule, and incorporated significant process improvements which is a testament to the CellRight team."
Couldwell said the move was an "important strategic milestone" in the group's long-term commercial strategy, and he was "pleased" that the operational synergies were developing as expected.
"As a result we now have greater flexibility to explore new product opportunities to meet patient demand, expanding the markets we operate in with a reduced manufacturing risk profile."
Related share prices |
---|
Tissue Regenix Group (TRX) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price